Showing results (241-250 of 387) with videos related to

Sort By:
Pageof 39
Brain and Language|May 21, 2017
Longitudinal decline in speech production in Parkinson's disease spectrum disordersSharon Ash, Charles Jester, Collin York, et al.
Clinical Parkinsonism & Related Disorders|December 4, 2023
Internal tremor in people with Parkinson's Disease: Demographic characteristics and comorbid symptomsLana M Chahine, Lakshmi Arbatti, Abhishek Hosamath, et al.
Neurology|September 13, 2015
Longitudinal study of normal cognition in Parkinson diseaseKara Pigott, Jacqueline Rick, Sharon X Xie, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 8, 2015
Development and initial testing of the Penn Parkinson's Daily Activities QuestionnaireLaura Brennan, Andrew Siderowf, Jonathan D Rubright, et al.
Parkinsonism & Related Disorders|August 19, 2022
Natural speech markers of Alzheimer's disease co-pathology in Lewy body dementiasSanjana Shellikeri, Sunghye Cho, Katheryn A Q Cousins, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 4, 2021
Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson DiseaseWhitley W Aamodt, Teresa Waligorska, Junchao Shen, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 12, 2010
Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomesDaniel Weintraub, Paul B Rosenberg, Lea T Drye, et al.
Journal of Parkinson'S Disease|April 26, 2024
In Their Own Words: Fears Expressed by People with Parkinson's Disease in an Online Symptom DatabaseSneha Mantri, Jennifer L Purks, Daniel Kinel, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|January 21, 2010
Sertraline for the treatment of depression in Alzheimer diseasePaul B Rosenberg, Lea T Drye, Barbara K Martin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 3, 2018
Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medicationsAlberto J Espay, Michael T Guskey, James C Norton, et al.
Pageof 39